Anticoagulant therapy: we have to do better! A systematic review

被引:0
|
作者
Wiltink, Ed H. [1 ]
机构
[1] St Antonius Hosp, Dept Clin Pharm & Pharmacol, NL-3430 EM Nieuwegein, Netherlands
关键词
ADVERSE DRUG EVENTS; HOSPITAL ADMISSIONS; ATRIAL-FIBRILLATION; WARFARIN; ERRORS; PREVENTION; STROKE; RISK;
D O I
10.1136/ejhpharm-2013-000295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim Anticoagulant therapy is considered a high-risk medication strategy with a narrow therapeutic window and the need for close monitoring, particularly with vitamin K antagonists. The nature of the drugs as well as the way they are administered make it more likely mistakes will occur. At all stages of care, ambulatory as well as in hospital, avoidable medication errors are seen. This review was performed to elucidate the number and nature of medication errors with anticoagulants and to look at possibilities for improving anticoagulant therapy. Methods A literature review was performed in PubMed, Medline and other sources looking after articles concerning medication errors in which anticoagulants are separately mentioned. From these articles, the risk factors were identified. Results A total of 17 papers were selected where medication errors with anticoagulant drugs were described. It became clear that medication errors occur from the doctor prescribing the medication, to the compliance of the patient with taking the treatment, and all steps in between. Communication between caregivers and between caregivers and patients seems to be an important factor. Conclusions This review shows that improvement is possible throughout the whole anticoagulant medication chain, starting with instructions for those prescribing drugs to education for patients.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 50 条
  • [1] We Must Do Better-We Have To Do Better
    Hughes, Bob
    FISHERIES, 2013, 38 (10) : 431 - 431
  • [2] We will have to do better
    Brack, D
    WORLD TODAY, 2002, 58 (8-9): : 4 - 7
  • [3] 2003: We have to do better
    Verma, IM
    MOLECULAR THERAPY, 2003, 7 (01) : 1 - 1
  • [4] Improvement in Adherence to Guidelines for Anticoagulant Therapy of Atrial Fibrillation: We Can Still Do Better
    Erkol, Ayhan
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2023, 51 (02): : 85 - 87
  • [5] A systematic review on vaginal laser therapy for treating stress urinary incontinence: Do we have enough evidence?
    Pergialiotis, Vasilios
    Prodromidou, Anastasia
    Perrea, Despina N.
    Doumouchtsis, Stergios K.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 (10) : 1445 - 1451
  • [6] A systematic review on vaginal laser therapy for treating stress urinary incontinence: Do we have enough evidence?
    Vasilios Pergialiotis
    Anastasia Prodromidou
    Despina N. Perrea
    Stergios K. Doumouchtsis
    International Urogynecology Journal, 2017, 28 : 1445 - 1451
  • [7] A Systematic Review on Vaginal Laser Therapy for Treating Stress Urinary Incontinence: Do We Have Enough Evidence?
    Pergialiotis, Vasilios
    Prodromidou, Anastasia
    Perrea, Despina N.
    Doumouchtsis, Stergios K.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (01) : 17 - 18
  • [8] The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review
    Tropeano, Angelo
    Corica, Domenico
    Li Pomi, Alessandra
    Pepe, Giorgia
    Morabito, Letteria Anna
    Curatola, Selenia Lorenza
    Casto, Celeste
    Aversa, Tommaso
    Wasniewska, Malgorzata
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (02) : 265 - 278
  • [9] Individualizing therapy: Do we have the tools to do it?
    Shaw, Jonathan E.
    Bloomgarden, Zachary T.
    JOURNAL OF DIABETES, 2015, 7 (01) : 1 - 2
  • [10] Do We Have Enough Evidence to Implement Particle Therapy as Standard Treatment in Lung Cancer? A Systematic Literature Review
    Pijls-Johannesma, Madelon
    Grutters, Janneke P. C.
    Verhaegen, Frank
    Lambin, Philippe
    De Ruysscher, Dirk
    ONCOLOGIST, 2010, 15 (01): : 93 - 103